CareDx, Inc. (CDNA) is a publicly traded Healthcare sector company. As of September 2, 2026, CDNA trades at $49.34 with a market cap of $2.59B and a P/E ratio of 22.80. CDNA moved +0.76% today. Year to date, CDNA is +155.85%; over the trailing twelve months it is +253.57%. Its 52-week range spans $10.96 to $53.67. Analyst consensus is buy with an average price target of $47.75. Rallies surfaces CDNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CDNA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $49.34 |
| Market Cap | $2.59B |
| P/E Ratio | 22.80 |
| EPS | $2.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $53.67 |
| 52-Week Low | $10.96 |
| Volume | 338.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $458.09M |
| Net Income | $111.01M |
| Gross Margin | 0.00% |
5 analysts cover CDNA: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $47.75.